Xinzhi Biotech announced that it plans to purchase 100% of Tsingbohua's shares held by shareholders of Beijing Qingbohua Technology Co., Ltd. by issuing shares and paying in cash. In order to ensure fair disclosure of information, protect investors' interests, and avoid causing abnormal fluctuations in the company's stock price, trading of the company's shares was suspended from July 16, 2026, and trading is expected to resume before July 30, 2026. During the suspension period, the company will promptly fulfill its information disclosure obligations according to the progress of important matters, and disclose the progress of related matters every 5 trading days.

Xinzhi Biotech announced that it plans to purchase 100% of Tsingbohua's shares held by shareholders of Beijing Qingbohua Technology Co., Ltd. by issuing shares and paying in cash. In order to ensure fair disclosure of information, protect investors' interests, and avoid causing abnormal fluctuations in the company's stock price, trading of the company's shares was suspended from July 16, 2026, and trading is expected to resume before July 30, 2026. During the suspension period, the company will promptly fulfill its information disclosure obligations according to the progress of important matters, and disclose the progress of related matters every 5 trading days.